| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 06/13/2007 | EP1104993B1 C3a serum-free clonal cell line and methods of use |
| 06/13/2007 | EP1071798B9 Constructs for controlled expression of recombinant proteins in prokaryotic cells |
| 06/13/2007 | EP1037909B1 Postweaning multisystemic wasting syndrome virus from pigs |
| 06/13/2007 | EP0954330B1 Intestinal trefoil proteins |
| 06/13/2007 | EP0915909B1 Insecticidal protein toxins from xenorhabdus |
| 06/13/2007 | EP0792278B1 Tumor necrosis factor-gamma |
| 06/13/2007 | EP0742902B2 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
| 06/13/2007 | CN2910940Y Production line for extraction of shrimp head peptide protein and chitin |
| 06/13/2007 | CN1981054A Methods for treating cancer using anti-WNT2 monoclonal antibodies and sirna |
| 06/13/2007 | CN1981049A Truncated adamts molecules |
| 06/13/2007 | CN1981036A Microbially expressed xylanases and their use as feed additives and other uses |
| 06/13/2007 | CN1980953A Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 06/13/2007 | CN1978648A Human hNRBF2 gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978647A Human hN027 gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978646A Human hNmrr gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978645A Human hNIF3 s gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978644A Human hNGT gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978643A Human hMSC gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1978642A Human hLDP gene sequence, and its coded protein and preparing method |
| 06/13/2007 | CN1977971A Mutant forms of cholera holotoxin as an adjuvant |
| 06/13/2007 | CN1321192C Method for preparing egg white peptide by enzyme method hydrolyzing egg white |
| 06/13/2007 | CN1321183C Polypeptide with Beta-lactamase inhibiting activity and its coded DNA |
| 06/13/2007 | CN1321130C Biologic preparation method of cyclic dipeptide analogue compound and uses thereof |
| 06/12/2007 | US7230167 Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 06/12/2007 | US7230085 Anti-DOTA antibody |
| 06/12/2007 | US7230084 Therapeutic using a bispecific antibody |
| 06/12/2007 | US7230083 Genetic engineered vitronectin receptors; restenosis therapy, anticancer agents |
| 06/12/2007 | US7230081 Interferon gamma conjugates |
| 06/12/2007 | US7230075 Coccidiosis poultry vaccine |
| 06/12/2007 | US7230073 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering |
| 06/12/2007 | US7229962 A fusion protein is dimerized with two soluble extracellular domains of proteins by intermolecular disulfide bonds, formation/s-s/; improved stability and therapeutic effects |
| 06/12/2007 | US7229824 Therapeutic bioactive ribonucleases for use in the tissue targeted therapy against tumors; tumor cytotoxic factors; antitumor agents |
| 06/12/2007 | US7229823 Methods for increasing the efficiency of recombinant AAV product |
| 06/12/2007 | US7229822 Melanoma differentation associated gene-5 and vectors and cells containing same |
| 06/12/2007 | US7229814 vector; host cell; nucleotide sequence encodes at least one enzyme involved in biosynthesizing cryptophycin |
| 06/12/2007 | US7229813 Everninomicin biosynthetic proteins |
| 06/12/2007 | US7229812 improved stability in the state of a liquid, an excellent substrate specificity and a lowered action on proline; reagent for measuring creatinine |
| 06/12/2007 | US7229811 2,5-diketo-D-gluconic acid (2,5-DKG) permeases; conversion of an inexpensive sugar source, such as D- glucose, to a stable precursor of ascorbic acid, 2-keto -L- gulonic acid (2-KLG) and eventually to ascorbic acid by chemical/enzymatic |
| 06/12/2007 | US7229797 reacting deoxyribose 1-phosphate and a nucleobase and catalyzing with a purine nucleoside phosphorylase; deoxyribonucleoside and inorganic phosphate are formed; inorganic phosphate is removed by phosphorylation of a substrate with said inorganic phosphate |
| 06/12/2007 | US7229794 Escherichia coli can produce L-threonine and includes prokaryotic and eukaryotic microorganisms having an inactivated galR gene |
| 06/12/2007 | US7229793 nucleic acid sequence encoding a signal peptide; a nucleic acid sequence which encodes the pro-region of a somatostatin or a functional fragment or variant thereof; pro-region somatostatin/peptide fusions reduce degradation of small peptides such as glucagon-like peptide, thereby increasing the half-life |
| 06/12/2007 | US7229792 Method of producing recombinant proteins |
| 06/12/2007 | US7229791 Attenuated Coryneform bacteria, which express attenuated amounts MtrA and/or MtrB proteins or gene products that have response regulator or histidine protein kinase activity |
| 06/12/2007 | US7229789 Methods and compositions for extracting proteins from cells |
| 06/12/2007 | US7229788 Mutating one or more of the amino acid residues of the amino acid sequence, in the tropoelastin, so that susceptibility of the tropoelastin to cleavage by thrombin, kallikrein or serum is reduced |
| 06/12/2007 | US7229787 Method of N-terminal cleavage using an aminopeptidase |
| 06/12/2007 | US7229773 Screening method for apoptosis-suppressing or-promoting substance |
| 06/12/2007 | US7229755 Isolating a biological specimen from a human; testing the specimen for an alteration in a human MSH2 nucleotide sequence or its expression product; comparing the results obtained with the results obtained from a wild type control |
| 06/12/2007 | US7229628 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/12/2007 | US7229619 Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
| 06/12/2007 | US7229618 complex of Synagis light chain and N-terminal fragment of Synagis heavy chain; precipitated with polyethylene glycol from propanol solution; for screening for, identifying and/or designing compounds that bind and/or modulate a biological activity of respiratory syncytial virus |
| 06/12/2007 | CA2319699C Placental protein 13 |
| 06/12/2007 | CA2215834C Dna encoding human papillomavirus type 18 |
| 06/12/2007 | CA2214649C Antigen presenting system and methods for activation of t-cells |
| 06/12/2007 | CA2198251C Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections |
| 06/12/2007 | CA2148252C Interaction trap system for isolating novel proteins |
| 06/12/2007 | CA2113712C Papilloma virus vaccine |
| 06/12/2007 | CA2076839C Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome |
| 06/12/2007 | CA2072620C Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 06/12/2007 | CA1341530C Inhibitors of angiogenin |
| 06/07/2007 | WO2007064462A1 Phage particle diagnostic reagents |
| 06/07/2007 | WO2007063903A1 Novel peptide compound |
| 06/07/2007 | WO2007063825A1 Monoclonal antibody directed against cd166 and method for production thereof |
| 06/07/2007 | WO2007063691A1 Bacteriolytic agent |
| 06/07/2007 | WO2007063299A1 Method for the purification of alpha-1-antitrypsin |
| 06/07/2007 | WO2007062466A1 Demibodies: dimerisation-activated therapeutic agents |
| 06/07/2007 | WO2007048127A9 Fc labeling for immunostaining and immunotargeting |
| 06/07/2007 | WO2007021900A3 Compositions and methods for treating wounds |
| 06/07/2007 | WO2006113957A3 Production of recombinant proteins by autoproteolytic cleavage of a fusion protein |
| 06/07/2007 | WO2006074450A3 Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases |
| 06/07/2007 | WO2006058202A3 Mer diagnostic and therapeutic agents |
| 06/07/2007 | US20070130630 Cell with improved secretion mediated by mrga protein or homologue |
| 06/07/2007 | US20070130629 Renal Regulatory Elements and Methods of Use Thereof |
| 06/07/2007 | US20070130628 Method for producing immortalised antibodies-secreting cells |
| 06/07/2007 | US20070129322 Recombinant protective protein from Streptococcus pneumoniae |
| 06/07/2007 | US20070129302 Il-17c antagonists and methods of using the same |
| 06/07/2007 | US20070129300 Cytotoxic factors for modulating cell death |
| 06/07/2007 | US20070128721 Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| 06/07/2007 | US20070128701 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 06/07/2007 | US20070128700 Methods to culture circovirus |
| 06/07/2007 | US20070128699 Using formation of binding complex between oncogenic human papilloma viral protein E6 and PDZ domain protein as diagnostic indicator of cell proliferative disorders |
| 06/07/2007 | US20070128698 Peptide constructs for treating autoimmune and related diseases |
| 06/07/2007 | US20070128697 gene therapy; neural epidermal growth factor-like 1(NELL); promoting cartilage formation or repair |
| 06/07/2007 | US20070128696 Recombinant DNA, gene expression vectors, and transformants capable of expressing a gene without inducing gene expression with an inducer; genetic engineering |
| 06/07/2007 | US20070128695 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/07/2007 | US20070128694 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 06/07/2007 | US20070128693 Method for the inactivation and removal of dengue virus from biological samples |
| 06/07/2007 | US20070128692 Chimeric empty capsids of the infectious bursal disease viruse (ibdv), obtainment process and applications |
| 06/07/2007 | US20070128691 Genomically modified cell neutralized to serum-free system |
| 06/07/2007 | US20070128690 gene sequences isolated from Trichoderma reesei; two genes encoding proteins comprising a cellulose binding domain, one encoding an arabinofuranosidase and one encoding an acetylxylanesterase; useful in textile and detergent industry and in pulp and paper industry; for converting biomass to sugars |
| 06/07/2007 | US20070128689 Reca-negative and rhab-negative microorganism |
| 06/07/2007 | US20070128688 Method for cell-free protein synthesis using complementary oligonucleotide |
| 06/07/2007 | US20070128687 Process for producing dipeptides |
| 06/07/2007 | US20070128683 Reacting pantetheine with a reporter to form labeled pantetheine; phosphorylating labeled pantetheine; forming phosphopantetheine; adenylating the labeled phosphopantetheine; forming labeled dephosphoCoenzyme A; phosphorylating 3'-hydrozyl of labeled dephosphoCoenzyme A; recover labeled coenzyme A analog |
| 06/07/2007 | US20070128672 Complementarity determining region (CDR); cancer, rheumatoid arthritis; immunology |
| 06/07/2007 | US20070128662 Photoreactive regulator of protein function and methods of use thereof |
| 06/07/2007 | US20070128653 Human HAC3 |
| 06/07/2007 | US20070128651 Promoter sequences and the use thereof |
| 06/07/2007 | US20070128642 Clearing misfolded proteins from blood via incubation with proteon nucleation center (PNC) which comprise metallic nanoparticles consisting of copper, zinc and/or iron; diagnosing metabolic disorders |
| 06/07/2007 | US20070128633 Cell-free protein expression systems and methods of use thereof |